Biofrontera completes US rights acquisition and closes $2.5 million offering
PositiveFinancial Markets

Biofrontera has successfully completed its acquisition of US rights and closed a $2.5 million offering, marking a significant step in its expansion strategy. This move not only strengthens its market presence but also enhances its ability to deliver innovative dermatological solutions. The successful funding round reflects investor confidence in Biofrontera's potential, which is crucial for its growth and development in the competitive healthcare landscape.
— Curated by the World Pulse Now AI Editorial System












